Literature DB >> 17586832

The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy.

C de Klerk1, N S Macklon, E M E W Heijnen, M J C Eijkemans, B C J M Fauser, J Passchier, J A M Hunfeld.   

Abstract

BACKGROUND: Failure of IVF treatment after a number of cycles can be devastating for couples. Although mild IVF strategies reduce the psychological burden of treatment, failure may cause feelings of regret that a more aggressive approach, including the transfer of two embryos, was not employed. In this study, the impact of treatment failure after two or more cycles on stress was studied, following treatment with a mild versus a standard treatment strategy.
METHODS: Randomized controlled two-centre trial (ISRCTN35766970). Women were randomized to undergo mild ovarian stimulation (including GnRH antagonist co-treatment) and single embryo transfer (n = 197) or standard GnRH agonist long-protocol ovarian stimulation with double embryo transfer (n = 194). Participants completed the Hospital Anxiety and Depression Scale prior to commencing treatment and 1 week after the outcome of their final treatment cycle was known. Data from women who underwent two or more IVF cycles were subject to analysis (n = 253).
RESULTS: Women who experienced treatment failure after standard IVF treatment presented more symptoms of depression 1 week after treatment termination compared with women who had undergone mild IVF: adjusted mean (+/-95% confidence interval) = 10.2 (+/-2.3) versus 5.4 (+/-1.8), respectively, P = 0.01.
CONCLUSIONS: Failure of IVF treatment after a mild treatment strategy may result in fewer short-term symptoms of depression as compared to failure after a standard treatment strategy. These findings may further encourage the application of mild IVF treatment strategies in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17586832     DOI: 10.1093/humrep/dem171

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  20 in total

1.  Efficacy and safety of late-start Corifollitropin-alfa administration for controlled ovarian hyperstimulation in IVF: a cohort, case-control study.

Authors:  Alberto Revelli; Giulia Pittatore; Simona Casano; Stefano Canosa; Francesca Evangelista; Chiara Benedetto
Journal:  J Assist Reprod Genet       Date:  2015-01-15       Impact factor: 3.412

2.  Precycle Estradiol in Synchronization and Scheduling of Antagonist Cycles.

Authors:  Shilpa Saple; Mukesh Agrawal; Simi Kawar
Journal:  J Obstet Gynaecol India       Date:  2016-04-29

3.  The combination of calcium ionophore A23187 and GM-CSF can safely salvage aged human unfertilized oocytes after ICSI.

Authors:  Konstantinos A Economou; Dimitra Christopikou; Erika Tsorva; Stephen Davies; Minas Mastrominas; Haris Cazlaris; Michael Koutsilieris; Panagoula Angelogianni; Dimitris Loutradis
Journal:  J Assist Reprod Genet       Date:  2016-10-14       Impact factor: 3.412

4.  Psychological distress and in vitro fertilization outcome.

Authors:  Lauri A Pasch; Steven E Gregorich; Patricia K Katz; Susan G Millstein; Robert D Nachtigall; Maria E Bleil; Nancy E Adler
Journal:  Fertil Steril       Date:  2012-06-13       Impact factor: 7.329

5.  MILD ovarian stimulation with GnRH-antagonist vs. long protocol with low dose FSH for non-PCO high responders undergoing IVF: a prospective, randomized study including thawing cycles.

Authors:  Simona Casano; Daniela Guidetti; Ambra Patriarca; Giulia Pittatore; Gianluca Gennarelli; Alberto Revelli
Journal:  J Assist Reprod Genet       Date:  2012-10-20       Impact factor: 3.412

6.  Balancing selected medication costs with total number of daily injections: a preference analysis of GnRH-agonist and antagonist protocols by IVF patients.

Authors:  E Scott Sills; Gary S Collins; Shala A Salem; Christopher A Jones; Alison C Peck; Rifaat D Salem
Journal:  Reprod Biol Endocrinol       Date:  2012-08-30       Impact factor: 5.211

Review 7.  Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization.

Authors:  Alberto Revelli; Simona Casano; Francesca Salvagno; Luisa Delle Piane
Journal:  Reprod Biol Endocrinol       Date:  2011-02-16       Impact factor: 5.211

8.  Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients.

Authors:  Ernesto Bosch; Diego Ezcurra
Journal:  Reprod Biol Endocrinol       Date:  2011-06-21       Impact factor: 5.211

9.  SULF 1 gene polymorphism, rs6990375 is in significant association with fetus failure in IVF technique.

Authors:  Eskandar Taghizadeh; Seyed Mehdi Kalantar; Reza Mahdian; Mohammad Hasan Sheikhha; Ehsan Farashahi-Yazd; Saeed Ghasemi; Zahra Shahbazi
Journal:  Iran J Reprod Med       Date:  2015-04

10.  Fertility patients and their prescriptions: a two-year audit of patient-pharmacist interactions in a reproductive endocrinology practice.

Authors:  Eric Scott Sills; Serhiy A Shurpyak; Deirdre J Gorman; Lyuda V Shkrobot; Grainne U Murray; Beppi Mg O'Connor; Una E Rapple; Alicia O Fogarty; Pavlina Sarkova; Kathy M Brickell; David J Walsh
Journal:  Int Arch Med       Date:  2009-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.